Stroke Center Awards & Recognition

The Joint Commission Comprehensive Stroke Center Designation

The Joint Commission is a nonprofit, independent agency that accredits and certifies more than 21,000 healthcare organizations and programs in the United States. UVA is designated a Comprehensive Stroke Center by The Joint Commission, meaning we're ready 24/7 to treat even the most complex stroke cases. Hospitals designated Primary Stroke Centers frequently send complex cases to us for treatment. We also coordinate care for stroke patients after they go home from the hospital and do research that leads to better care for stroke patients. 

The American Heart Association & American Stroke Association Honors

The American Heart Association & American Stroke Association (AHA & ASA) is a national voluntary health agency to help reduce disability and death from cardiovascular diseases and stroke. As one of the most trusted sources of scientific information in cardiovascular and stroke medicine, this organization honors hospitals that consistently follow the most up-to-date guidelines for treatment.

Patients with life-threatening cardiovascular disease or stroke who go to hospitals that follow these guidelines are more likely to live and are less likely to return to the hospital for the same problem, according to the AHA & ASA. UVA received the following awards from the AHA & ASA for stroke care.

Get with the Guidelines Gold Plus award logo

Get with the Guidelines®: Stroke Gold Plus

UVA received this award for reaching the goal of treating patients with 85% or higher compliance to standard levels of care as outlined by the AHA & ASA for 24 consecutive months. That means we followed guidelines set by the AHA & ASA more than 85% of the time for a period of two years. It also means that we were in compliance 75% of the time to special heart failure and stroke quality measures during a 1-year period.

Target: Stroke Honor Roll Elite Plus

We received this award for reaching the goal of providing tissue plasminogen activator (tPA), a clot-busting drug, to 85% of eligible stroke patients within 60 minutes of their arrival. This improves their outcomes.